annual accounts payable:
$4.34B-$391.00M(-8.26%)Summary
- As of today (May 21, 2025), GSK annual accounts payable is $4.34 billion, with the most recent change of -$391.00 million (-8.26%) on December 31, 2024.
- During the last 3 years, GSK annual accounts payable has fallen by -$1.78 billion (-29.03%).
- GSK annual accounts payable is now -60.33% below its all-time high of $10.95 billion, reached on December 31, 2009.
Performance
GSK Accounts payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly accounts payable:
$19.60B+$15.25B(+351.15%)Summary
- As of today (May 21, 2025), GSK quarterly accounts payable is $19.60 billion, with the most recent change of +$15.25 billion (+351.15%) on March 31, 2025.
- Over the past year, GSK quarterly accounts payable has increased by +$1.14 billion (+6.17%).
- GSK quarterly accounts payable is now -33.69% below its all-time high of $29.55 billion, reached on March 31, 2018.
Performance
GSK quarterly accounts payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Accounts payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
GSK Accounts payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -8.3% | +6.2% |
| 3 y3 years | -29.0% | -15.1% |
| 5 y5 years | -20.1% | +3.5% |
GSK Accounts payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -29.0% | at low | -15.1% | +351.1% |
| 5 y | 5-year | -29.0% | at low | -15.1% | +351.1% |
| alltime | all time | -60.3% | +4879.5% | -33.7% | >+9999.0% |
GSK Accounts payable History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $19.60B(+351.2%) |
| Dec 2024 | $4.34B(-8.3%) | $4.34B(-77.4%) |
| Sep 2024 | - | $19.24B(+6.8%) |
| Jun 2024 | - | $18.02B(-2.4%) |
| Mar 2024 | - | $18.46B(+289.8%) |
| Dec 2023 | $4.74B(+1.2%) | $4.74B(-75.1%) |
| Sep 2023 | - | $19.01B(+8.0%) |
| Jun 2023 | - | $17.60B(-0.4%) |
| Mar 2023 | - | $17.67B(+277.7%) |
| Dec 2022 | $4.68B(-23.6%) | $4.68B(-74.0%) |
| Sep 2022 | - | $18.00B(+0.2%) |
| Jun 2022 | - | $17.96B(-22.2%) |
| Mar 2022 | - | $23.09B(+277.2%) |
| Dec 2021 | $6.12B(+3.1%) | $6.12B(-70.1%) |
| Sep 2021 | - | $20.45B(+3.6%) |
| Jun 2021 | - | $19.75B(-1.7%) |
| Mar 2021 | - | $20.08B(+238.2%) |
| Dec 2020 | $5.94B(+9.3%) | $5.94B(-69.5%) |
| Sep 2020 | - | $19.48B(+2.4%) |
| Jun 2020 | - | $19.02B(+0.4%) |
| Mar 2020 | - | $18.94B(+248.6%) |
| Dec 2019 | $5.43B(+17.5%) | $5.43B(-70.0%) |
| Sep 2019 | - | $18.11B(+6.8%) |
| Jun 2019 | - | $16.96B(-3.1%) |
| Mar 2019 | - | $17.51B(+278.6%) |
| Dec 2018 | $4.63B(-3.0%) | $4.63B(-72.9%) |
| Sep 2018 | - | $17.06B(+4.0%) |
| Jun 2018 | - | $16.40B(-44.5%) |
| Mar 2018 | - | $29.55B(+519.9%) |
| Dec 2017 | $4.77B(+7.9%) | $4.77B(-82.1%) |
| Sep 2017 | - | $26.64B(+4.6%) |
| Jun 2017 | - | $25.47B(+69.7%) |
| Mar 2017 | - | $15.01B(+239.8%) |
| Dec 2016 | $4.42B(-4.4%) | $4.42B(-70.9%) |
| Sep 2016 | - | $15.18B(+3.7%) |
| Jun 2016 | - | $14.65B(-1.6%) |
| Mar 2016 | - | $14.89B(+222.2%) |
| Dec 2015 | $4.62B(+6.4%) | $4.62B(-64.2%) |
| Sep 2015 | - | $12.90B(+0.6%) |
| Jun 2015 | - | $12.82B(+0.8%) |
| Mar 2015 | - | $12.72B(+193.0%) |
| Dec 2014 | $4.34B(-3.9%) | $4.34B(-64.5%) |
| Sep 2014 | - | $12.25B(+3.5%) |
| Jun 2014 | - | $11.84B(-2.6%) |
| Mar 2014 | - | $12.15B(+169.0%) |
| Dec 2013 | $4.52B(+4.8%) | $4.52B(-64.2%) |
| Sep 2013 | - | $12.60B(+5.4%) |
| Jun 2013 | - | $11.95B(+2.0%) |
| Mar 2013 | - | $11.72B(+172.1%) |
| Dec 2012 | $4.31B(+8.9%) | $4.31B(-65.4%) |
| Sep 2012 | - | $12.47B(+12.2%) |
| Jun 2012 | - | $11.11B(-1.3%) |
| Mar 2012 | - | $11.26B(+184.6%) |
| Dec 2011 | $3.96B(+19.7%) | $3.96B(-64.6%) |
| Sep 2011 | - | $11.19B(-4.2%) |
| Jun 2011 | - | $11.68B(+0.3%) |
| Mar 2011 | - | $11.64B(+252.4%) |
| Dec 2010 | $3.30B | $3.30B(-69.3%) |
| Sep 2010 | - | $10.75B(+9.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2010 | - | $9.81B(-4.9%) |
| Mar 2010 | - | $10.32B(-5.8%) |
| Dec 2009 | $10.95B(+23.1%) | $10.95B(+12.5%) |
| Sep 2009 | - | $9.73B(+14.6%) |
| Jun 2009 | - | $8.50B(+3.0%) |
| Mar 2009 | - | $8.25B(-7.3%) |
| Dec 2008 | $8.90B(-7.9%) | $8.90B(-2.9%) |
| Sep 2008 | - | $9.16B(-13.4%) |
| Jun 2008 | - | $10.59B(+0.1%) |
| Mar 2008 | - | $10.57B(+9.4%) |
| Dec 2007 | $9.66B(+470.7%) | $9.66B(-8.1%) |
| Sep 2007 | - | $10.51B(+19.7%) |
| Jun 2007 | - | $8.78B(-1.6%) |
| Mar 2007 | - | $8.92B(+426.9%) |
| Dec 2006 | $1.69B(+20.2%) | $1.69B(-80.4%) |
| Sep 2006 | - | $8.63B(+4.0%) |
| Jun 2006 | - | $8.30B(-3.1%) |
| Mar 2006 | - | $8.57B(+508.3%) |
| Dec 2005 | $1.41B(-82.8%) | $1.41B(-82.6%) |
| Sep 2005 | - | $8.08B(+5.6%) |
| Jun 2005 | - | $7.65B(-2.6%) |
| Mar 2005 | - | $7.85B(-4.1%) |
| Dec 2004 | $8.19B(+568.4%) | $8.19B(+8.2%) |
| Sep 2004 | - | $7.56B(+6.1%) |
| Jun 2004 | - | $7.13B(-47.1%) |
| Mar 2004 | - | $13.47B(+999.6%) |
| Dec 2003 | $1.22B(+6.2%) | $1.22B(-89.2%) |
| Sep 2003 | - | $11.29B(+2.7%) |
| Jun 2003 | - | $10.99B(-2.5%) |
| Mar 2003 | - | $11.28B(+878.2%) |
| Dec 2002 | $1.15B(+4.5%) | $1.15B(-89.8%) |
| Sep 2002 | - | $11.29B(+0.2%) |
| Jun 2002 | - | $11.27B(+6.1%) |
| Mar 2002 | - | $10.62B(+862.6%) |
| Dec 2001 | $1.10B(-8.9%) | $1.10B(-89.5%) |
| Sep 2001 | - | $10.54B(+9.8%) |
| Jun 2001 | - | $9.60B(-7.3%) |
| Mar 2001 | - | $10.36B(+755.9%) |
| Dec 2000 | $1.21B(+104.1%) | $1.21B(-85.5%) |
| Sep 2000 | - | $8.35B(-1.2%) |
| Jun 2000 | - | $8.45B(-0.3%) |
| Mar 2000 | - | $8.48B(+1329.7%) |
| Dec 1999 | $593.03M(+22.4%) | $593.03M(+25.9%) |
| Jun 1999 | - | $470.92M(-2.8%) |
| Dec 1998 | $484.59M(-2.1%) | $484.59M(-74.8%) |
| Jun 1998 | - | $1.93B(+288.8%) |
| Dec 1997 | $495.17M(+7.9%) | $495.17M(+7.9%) |
| Dec 1996 | $458.86M(+1.0%) | $458.86M(-87.2%) |
| Dec 1995 | $454.50M(-87.3%) | - |
| Jun 1995 | - | $3.59B(+1138.5%) |
| Jun 1995 | $3.59B(+1138.5%) | - |
| Jun 1994 | $289.61M(+7.8%) | $289.61M(+7.8%) |
| Jun 1993 | $268.55M(-12.8%) | $268.55M(-12.8%) |
| Jun 1992 | $307.80M(+30.0%) | $307.80M(+30.0%) |
| Jun 1991 | $236.84M(+1.4%) | $236.84M(+1.4%) |
| Jun 1990 | $233.56M(+33.4%) | $233.56M(+33.4%) |
| Jun 1989 | $175.13M(+7.9%) | $175.13M(+7.9%) |
| Jun 1988 | $162.34M(+32.7%) | $162.34M(+32.7%) |
| Jun 1987 | $122.35M(+40.3%) | $122.35M(+40.3%) |
| Jun 1986 | $87.24M | $87.24M |
FAQ
- What is GSK annual accounts payable?
- What is the all time high annual accounts payable for GSK?
- What is GSK annual accounts payable year-on-year change?
- What is GSK quarterly accounts payable?
- What is the all time high quarterly accounts payable for GSK?
- What is GSK quarterly accounts payable year-on-year change?
What is GSK annual accounts payable?
The current annual accounts payable of GSK is $4.34B
What is the all time high annual accounts payable for GSK?
GSK all-time high annual accounts payable is $10.95B
What is GSK annual accounts payable year-on-year change?
Over the past year, GSK annual accounts payable has changed by -$391.00M (-8.26%)
What is GSK quarterly accounts payable?
The current quarterly accounts payable of GSK is $19.60B
What is the all time high quarterly accounts payable for GSK?
GSK all-time high quarterly accounts payable is $29.55B
What is GSK quarterly accounts payable year-on-year change?
Over the past year, GSK quarterly accounts payable has changed by +$1.14B (+6.17%)